Literature DB >> 18971422

Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.

Boaz P Levi1, Omer H Yilmaz, Gregg Duester, Sean J Morrison.   

Abstract

High levels of aldehyde dehydrogenase (ALDH) activity have been proposed to be a common feature of stem cells. Adult hematopoietic, neural, and cancer stem cells have all been reported to have high ALDH activity, detected using Aldefluor, a fluorogenic substrate for ALDH. This activity has been attributed to Aldh1a1, an enzyme that is expressed at high levels in stem cells and that has been suggested to regulate stem cell function. Nonetheless, Aldh1a1 function in stem cells has never been tested genetically. We observed that Aldh1a1 was preferentially expressed in mouse hematopoietic stem cells (HSCs) and expression increased with age. Hematopoietic cells from Aldh1a1-deficient mice exhibited increased sensitivity to cyclophosphamide in a non-cell-autonomous manner, consistent with its role in cyclophosphamide metabolism in the liver. However, Aldh1a1 deficiency did not affect hematopoiesis, HSC function, or the capacity to reconstitute irradiated recipients in young or old adult mice. Aldh1a1 deficiency also did not affect Aldefluor staining of hematopoietic cells. Finally, Aldh1a1 deficiency did not affect the function of stem cells from the adult central or peripheral nervous systems. Aldh1a1 is not a critical regulator of adult stem cell function or Aldefluor staining in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971422      PMCID: PMC2647681          DOI: 10.1182/blood-2008-05-156752

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.

Authors:  Anna V Molofsky; Ricardo Pardal; Toshihide Iwashita; In-Kyung Park; Michael F Clarke; Sean J Morrison
Journal:  Nature       Date:  2003-10-22       Impact factor: 49.962

2.  Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness.

Authors:  Genevieve M Kruger; Jack T Mosher; Suzanne Bixby; Nancy Joseph; Toshihide Iwashita; Sean J Morrison
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

3.  Hirschsprung disease is linked to defects in neural crest stem cell function.

Authors:  Toshihide Iwashita; Genevieve M Kruger; Ricardo Pardal; Mark J Kiel; Sean J Morrison
Journal:  Science       Date:  2003-08-15       Impact factor: 47.728

Review 4.  Genetic dissection of retinoid dehydrogenases.

Authors:  G Duester
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

5.  Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization.

Authors:  S J Morrison; D E Wright; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  A stem cell molecular signature.

Authors:  Natalia B Ivanova; John T Dimos; Christoph Schaniel; Jason A Hackney; Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

Review 7.  Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism.

Authors:  Vasilis Vasiliou; Aglaia Pappa; Tia Estey
Journal:  Drug Metab Rev       Date:  2004-05       Impact factor: 4.518

8.  Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.

Authors:  Katherine I Oravecz-Wilson; Mark J Kiel; Lina Li; Dinesh S Rao; Djenann Saint-Dic; Priti D Kumar; Melissa M Provot; Kurt D Hankenson; Venkat N Reddy; Andrew P Lieberman; Sean J Morrison; Theodora S Ross
Journal:  Hum Mol Genet       Date:  2004-03-03       Impact factor: 6.150

9.  A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.

Authors:  Valérie Dupé; Nicolas Matt; Jean-Marie Garnier; Pierre Chambon; Manuel Mark; Norbert B Ghyselinck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina.

Authors:  Xiaohong Fan; Andrei Molotkov; Shin-Ichi Manabe; Christine M Donmoyer; Louise Deltour; Mario H Foglio; Arnold E Cuenca; William S Blaner; Stuart A Lipton; Gregg Duester
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more
  45 in total

1.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Authors:  Jan S Moreb; Deniz Ucar; Shuhong Han; John K Amory; Alex S Goldstein; Blanca Ostmark; Lung-Ji Chang
Journal:  Chem Biol Interact       Date:  2011-11-03       Impact factor: 5.192

Review 2.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Lung epithelial healing: a modified seed and soil concept.

Authors:  Susan D Reynolds; Heather M Brechbuhl; Mary Kathryn Smith; Russell W Smith; Moumita Ghosh
Journal:  Proc Am Thorac Soc       Date:  2012-05

4.  Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.

Authors:  Chong Chen; Lipeng Bai; Fengqi Cao; Shengnan Wang; Huiwen He; Mingcheng Song; Huilin Chen; Yan Liu; Jian Guo; Qin Si; Yundi Pan; Ruizhe Zhu; Tsung-Hsien Chuang; Rong Xiang; Yunping Luo
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

5.  Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.

Authors:  Cynthia A Morgan; Thomas D Hurley
Journal:  J Med Chem       Date:  2015-02-10       Impact factor: 7.446

6.  Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas.

Authors:  Meritxell Rovira; Sherri-Gae Scott; Andrew S Liss; Jan Jensen; Sarah P Thayer; Steven D Leach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

7.  Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.

Authors:  Garrett G Muramoto; J Lauren Russell; Rachid Safi; Alice B Salter; Heather A Himburg; Pamela Daher; Sarah K Meadows; Phuong Doan; Robert W Storms; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

Review 8.  Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.

Authors:  Vasilis Vasiliou; David C Thompson; Clay Smith; Mayumi Fujita; Ying Chen
Journal:  Chem Biol Interact       Date:  2012-11-16       Impact factor: 5.192

9.  ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.

Authors:  Yuchun Luo; Katiuscia Dallaglio; Ying Chen; William A Robinson; Steven E Robinson; Martin D McCarter; Jianbin Wang; Rene Gonzalez; David C Thompson; David A Norris; Dennis R Roop; Vasilis Vasiliou; Mayumi Fujita
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

Review 10.  Breast cancer stem cells: tools and models to rely on.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.